REQUEST A DEMO
Total
USD $0.00
Search more companies

Canixa Life Sciences Private Limited. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Canixa Life Sciences Private Limited. Profile Updated: August 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Canixa Life Sciences Private Limited. is an unlisted company, incorporated on 22/05/2007. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U24233DL2007PTC163800 and registration number is 163800. The company is a trade company, it is engaged in wholesale trading.

Legal Address
147, Doctors Apartment Vashundhara Enclave
East Delhi; Delhi; Postal Code: 110096

Contact Details: Purchase the Canixa Life Sciences Private Limited. report to view the information.

Website: http://www.canixalife.com

Basic Information
Total Employees:
Purchase the Canixa Life Sciences Private Limited. report to view the information.
Outstanding Shares:
Purchase the Canixa Life Sciences Private Limited. report to view the information.
Registered Capital:
Purchase the Canixa Life Sciences Private Limited. report to view the information.
Incorporation Date:
May 22, 2007
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Canixa Life Sciences Private Limited. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
30.33%
Total operating revenue
30.64%
Operating profit (EBIT)
14.43%
EBITDA
29.14%
Net Profit (Loss) for the Period
14.01%
Total assets
41.23%
Total equity
31.08%
Operating Profit Margin (ROS)
-1.27%
Net Profit Margin
-0.97%
Return on Equity (ROE)
-3.58%
Debt to Equity Ratio
14.1%
Quick Ratio
-0.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?